Market Capitalization Threshold for Hong Kong Main Board Listing: Minimum Requirements

The Hong Kong Exchanges and Clearing Limited (HKEX) published a consultation paper in December 2024 proposing to raise the minimum market capitalisation requirement for Main Board listing from HKD 500 million to HKD 600 million, a 20% increase that would be the first adjustment to this threshold since the current regime was established in 2018. This proposed change, which the HKEX expects to implement in the first half of 2025, comes at a time when the exchange is grappling with a sharp decline in new listings—only 70 IPOs raised a combined HKD 87.5 billion in 2024, down from 144 IPOs raising HKD 128.2 billion in 2021. The adjustment is part of a broader package of amendments to the Listing Rules aimed at strengthening market quality and investor protection, particularly for smaller issuers. For sponsors, underwriters, and prospective listing applicants, understanding the exact mechanics of the market capitalisation test—including how it interacts with the profit, revenue, and cash flow requirements under Chapter 8 of the Main Board Listing Rules—is essential for structuring transactions that will pass HKEX vetting. This article provides a granular breakdown of the current and proposed thresholds, the calculation methodology, and the practical implications for deal structuring.

The Three Financial Eligibility Tests and Their Market Cap Components

The HKEX Main Board Listing Rules under Chapter 8 provide three distinct financial eligibility tests for new applicants, each with its own minimum market capitalisation requirement. The “Profit Test” under Rule 8.05(1) requires a minimum market capitalisation of HKD 500 million at the time of listing. The “Market Capitalisation/Revenue Test” under Rule 8.05(2) demands HKD 4 billion. The “Market Capitalisation/Revenue/Cash Flow Test” under Rule 8.05(3) requires HKD 2 billion. These thresholds are not merely numerical hurdles; they serve as a proxy for the market’s assessment of the issuer’s value and, by extension, its suitability for a Main Board listing.

The Profit Test: HKD 500 Million (Current) / HKD 600 Million (Proposed)

Under the current Rule 8.05(1), an applicant must demonstrate a minimum market capitalisation of HKD 500 million at the time of listing, alongside a profit attributable to shareholders of at least HKD 35 million in the most recent financial year and HKD 45 million in aggregate over the three preceding financial years. The HKEX’s December 2024 consultation paper proposes raising this to HKD 600 million, aligning it with the nominal increase in market values since the threshold was last reviewed. This change would apply to all new listing applications submitted after the effective date, which the HKEX has indicated will be in Q1 2025.

The Market Capitalisation/Revenue Test: HKD 4 Billion

For issuers that cannot meet the profit requirement, Rule 8.05(2) provides an alternative pathway. The applicant must have a market capitalisation of at least HKD 4 billion at listing and revenue of at least HKD 500 million for the most recent audited financial year. This test is commonly used by pre-revenue biotech companies under Chapter 18A, which have their own additional requirements, and by high-growth technology firms. The HKD 4 billion threshold has remained unchanged since the test was introduced in 2018, and the December 2024 consultation paper does not propose adjusting it.

The Market Capitalisation/Revenue/Cash Flow Test: HKD 2 Billion

Rule 8.05(3) offers a middle ground. The applicant must have a market capitalisation of at least HKD 2 billion at listing, revenue of at least HKD 500 million for the most recent financial year, and positive cash flow from operating activities of at least HKD 100 million in aggregate over the three preceding financial years. This test is designed for issuers with strong revenue generation but inconsistent profitability. Like the HKD 4 billion threshold, the HKD 2 billion requirement is not being amended in the current consultation.

Calculation Methodology and Practical Considerations

The market capitalisation figure used for eligibility is not the same as the company’s valuation in a private funding round or a simple multiple of earnings. The HKEX requires that the market capitalisation be calculated based on the total number of issued shares at the time of listing, multiplied by the issue price. This means that the issue price itself must be set at a level that achieves the required market cap, and the underwriter must be confident that the market will support that valuation.

The Issue Price as the Anchor

Under Rule 8.05, the market capitalisation is determined by reference to the issue price in the prospectus. If the final issue price is lower than the price used in the pre-deal investor education, the market cap may fall below the threshold, jeopardising the listing. This creates a structural tension: the sponsor must price the offering high enough to meet the market cap requirement but low enough to ensure sufficient demand. In practice, this means that the issue price is often set at a discount to comparable listed companies to ensure full subscription, while still clearing the market cap hurdle.

Lock-Up Periods and Post-Listing Price Stability

The HKEX does not impose a mandatory lock-up on the market capitalisation after listing, but Rule 8.24 requires that the issuer maintain a sufficient public float—at least 25% of the total issued shares (or a lower percentage of HKD 1 billion to HKD 5 billion, as approved by the Exchange). If the market capitalisation falls below the threshold within the first few days of trading due to price volatility, the listing is not automatically revoked. However, a sustained decline below the threshold could trigger a review under Rule 8.04, which requires the issuer to maintain conditions for listing on an ongoing basis.

Interaction with Sponsor Due Diligence

The sponsor’s obligation under the SFC’s Code of Conduct for Persons Licensed by or Registered with the Securities and Futures Commission (the “SFC Code”), specifically paragraph 17.6, requires that the sponsor conduct reasonable due diligence on the valuation assumptions used to support the issue price. This includes reviewing comparable company analyses, discounted cash flow models, and any third-party valuation reports. If the sponsor cannot form a reasonable basis for the market capitalisation, the listing application will not proceed.

The December 2024 Consultation: Impact on Deal Structuring

The HKEX’s consultation paper, titled “Proposed Amendments to Listing Rules Relating to the Market Capitalisation Requirement for the Profit Test,” was published on 12 December 2024 with a consultation period ending on 28 February 2025. The key proposal is to raise the minimum market capitalisation under the Profit Test from HKD 500 million to HKD 600 million. This change is intended to “enhance the quality of issuers listed on the Main Board” and to “address the disconnect between the current threshold and the prevailing market conditions.”

Rationale for the Increase

The HKEX’s analysis shows that the median market capitalisation of Main Board issuers at the time of listing in 2023 was approximately HKD 1.2 billion, more than double the HKD 500 million threshold. This suggests that the current minimum is not binding for the vast majority of applicants. However, the exchange is concerned about a small number of issuers that list at or near the threshold and subsequently experience significant price declines, harming retail investors. The proposed HKD 600 million threshold would still be below the median, but it would raise the floor.

Transitional Arrangements

The consultation paper proposes that the new threshold would apply to all listing applications submitted on or after the effective date. Applications already submitted but not yet approved would be subject to the current HKD 500 million requirement, provided they are approved within six months of the effective date. This grandfathering provision is critical for sponsors with live mandates, as it creates a clear deadline for filing.

Implications for Pre-IPO Funding Rounds

For issuers targeting the Profit Test, a 20% increase in the market cap threshold means that the pre-IPO valuation must be correspondingly higher. This could affect the pricing of Series B and C funding rounds, which are typically set at a discount to the expected IPO valuation. If the sponsor is targeting HKD 600 million, the pre-IPO valuation might need to be in the range of HKD 400 million to HKD 500 million to provide a sufficient discount for IPO investors. This dynamic is particularly relevant for companies in the healthcare and technology sectors, where pre-IPO valuations are often based on revenue multiples rather than earnings.

Cross-Border Considerations and Jurisdictional Nuances

The market capitalisation requirement applies uniformly to all applicants, regardless of their place of incorporation. However, the mechanics of calculating market capitalisation can differ based on the issuer’s corporate structure, particularly for PRC companies using variable interest entity (VIE) structures or for Bermuda and Cayman Islands issuers with dual-class share structures.

VIE Structures and Market Cap Calculation

For PRC companies listed via a VIE structure, the market capitalisation is calculated on the listed entity in the Cayman Islands or BVI, not on the operating company in the PRC. This means that the issue price must reflect the consolidated value of the VIE, but the legal entity being valued is the offshore holding company. The HKEX’s Listing Decision LD43-3 (2018) confirms that the market capitalisation test applies to the listed group as a whole, including the VIE, provided the contractual arrangements are properly disclosed.

Dual-Class Share Structures

Issuers with weighted voting rights (WVR) structures under Chapter 8A of the Main Board Listing Rules must meet the same market capitalisation thresholds. However, the calculation becomes more complex because different classes of shares may have different economic rights. Under Rule 8A.06, the market capitalisation is calculated on the total issued share capital, including both the WVR shares and the ordinary shares, valued at the issue price of the ordinary shares. This means that the WVR shares, which typically have higher voting rights but the same economic rights, do not receive a valuation premium for market cap purposes.

Bermuda and Cayman Islands Issuers

For issuers incorporated in Bermuda or the Cayman Islands, the market capitalisation is calculated in the same manner as for Hong Kong-incorporated companies. However, the sponsor must ensure that the constitutional documents and the Companies Act of the relevant jurisdiction permit the issuance of shares at the price required to meet the threshold. This is rarely an issue in practice, as both jurisdictions have flexible corporate laws, but it is a standard due diligence item.

Actionable Takeaways

1. For sponsors managing live Profit Test mandates, the effective date of the proposed HKD 600 million threshold creates a hard deadline for filing—applications submitted after Q1 2025 must meet the higher requirement, so expedite documentation to secure the current HKD 500 million window.

2. Issuers targeting the Market Capitalisation/Revenue Test or the Market Capitalisation/Revenue/Cash Flow Test should note that the HKD 4 billion and HKD 2 billion thresholds are not proposed for amendment, making these pathways relatively more attractive for companies with strong revenue but modest profitability.

3. The issue price must be set with sufficient headroom above the market cap threshold to absorb post-listing price volatility without triggering a review under Rule 8.04, as a sustained decline below the minimum could jeopardise the issuer’s continued listing status.

4. Pre-IPO funding rounds for Profit Test applicants should be priced at a valuation that leaves room for a 15-20% IPO discount while still achieving the HKD 600 million market cap, which may require tightening the valuation range in Series B/C negotiations.

5. For PRC VIE-structure issuers, the market cap calculation must be stress-tested against the offshore holding company’s valuation alone, as the sponsor’s due diligence under SFC Code paragraph 17.6 must confirm that the consolidated VIE value is properly reflected in the issue price.